Semnur Pharmaceuticals, Inc. (SMNR) Form 10-K Annual Reports
Semnur Pharmaceuticals, Inc. (SMNR) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SMNR
CIK: 1913577
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Pipara & Co LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerChintan Jain
Audit LocationNew Delhi, India
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001193125-26-342594 | View SEC Doc Filr Page |
| 424B3 | 2026-07-07 | — | 424B3 | 0001193125-26-297098 | View SEC Doc Filr Page |
| 8-K | 2026-07-07 | 2026-07-03 | 8-K | 0001193125-26-297085 | View SEC Doc Filr Page |
| 424B3 | 2026-07-01 | — | 424B3 | 0001193125-26-291407 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-26 | — | SCHEDULE 13D/A Filing | 0001193125-26-285542 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-15 | 4 | 0001193125-26-285524 | View SEC Doc Filr Page |
| 8-K | 2026-06-25 | 2026-06-25 | 8-K | 0001193125-26-283007 | View SEC Doc Filr Page |
| 424B3 | 2026-06-15 | — | 424B3 | 0001193125-26-271242 | View SEC Doc Filr Page |
| 424B3 | 2026-06-15 | — | 424B3 | 0001193125-26-270270 | View SEC Doc Filr Page |
| EFFECT | 2026-05-18 | — | EFFECT Filing | 9999999995-26-001684 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001193125-26-221896 | View SEC Doc Filr Page |
| POS AM | 2026-05-12 | — | POS AM | 0001193125-26-219654 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001193125-26-197687 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-06-25 | DEF 14A | 0001193125-26-197655 | View SEC Doc Filr Page |
| 8-K | 2026-04-23 | 2026-04-20 | 8-K | 0001193125-26-173690 | View SEC Doc Filr Page |
| 8-K | 2026-03-17 | 2026-03-13 | 8-K | 0001193125-26-110816 | View SEC Doc Filr Page |
| 10-K | 2026-02-27 | 2025-12-31 | 10-K | 0001193125-26-082642 | View SEC Doc Filr Page |
| EFFECT | 2025-12-29 | — | EFFECT Filing | 9999999995-25-003932 | View SEC Doc Filr Page |
| 424B3 | 2025-12-29 | — | 424B3 | 0001193125-25-335407 | View SEC Doc Filr Page |
| CORRESP | 2025-12-23 | — | CORRESP Filing | 0001193125-25-330493 | View SEC Doc Filr Page |
| S-1/A | 2025-12-19 | — | S-1/A | 0001193125-25-326813 | View SEC Doc Filr Page |
| S-8 | 2025-12-03 | — | S-8 | 0001193125-25-306969 | View SEC Doc Filr Page |
| S-8 | 2025-12-03 | — | S-8 | 0001193125-25-306962 | View SEC Doc Filr Page |
| 8-K | 2025-12-03 | 2025-12-03 | 8-K | 0001193125-25-306757 | View SEC Doc Filr Page |
| 10-Q | 2025-11-12 | 2025-09-30 | 10-Q | 0001193125-25-277536 | View SEC Doc Filr Page |